MGC Pharma submits patent application for CimetrA to European IP Office
LONDON: MGC Pharmaceuticals Ltd (ASX: MXC) announced the successful submission of a patent application for CimetrA to the Slovenian Intellectual Property Office (SIPO), assigned to MGC Pharma. MGC Pharma submitted its patent application which was accepted by SIPO on 5…